Chemical Pathology Safety Data Sheet (SDS)
|Catalogue Number||Product Name|
|15010102||Alcohol and Ammonia – Full Program|
|15170102||Angiotensin-converting Enzyme- Full Program|
|15700102||Anti-Fungals – Full Program|
|15180102||Anti-Mullerian Hormone – Full Program|
|15030102||Bile Acids – Full Program|
|15580102||Biogenic Amines – Full Program|
|15040102||Blood Gases – Full Program|
|15060102||B-Natriuretic Peptide – Full Program|
|15070102||Body Fluids – Full Program|
|15690102||Bone Markers – Full Program|
|15080102||C Reactive Protein – Full Program|
|15090102||Compact Serum Chemistry – Full Program|
|15750102||Condensed Blood Gases – Full Program|
|15110102||Condensed PoCT Blood Gases – Full Program|
|15120102||Condensed PoCT Troponin and HCG – Full Program|
|15100102||Condensed Serum Chemistry – Full Program|
|15050102||CO-oximetry – Full Program|
|15140102||CSF: Chemistry – Full Program|
|15150102||CSF: Oligoclonal Bands – Full Program|
|15670102||Disaccharidases- Full Program|
|15160202||Dried Blood Spot – Full Program|
|15190102||Endocrine – Full Program|
|15220102||Endocrine Special – Full Program|
|15810102||Everolimus – Full Program|
|15230102||Faecal Occult Blood – Full Program|
|15720102||Foetal Fibronectin – Full Program|
|15240102||General Serum Chemistry – Full Program|
|15590102||General Urine Chemistry – Full Program|
|15250102||HbA1c: Lyophilised – Full Program|
|15650102||HbA1c: Whole Blood – Full Program|
|15260102||IGF-1/C Peptide – Full Program|
|15500102||Immunosuppressants – Full Program|
|15800102||Lactate Meters – Full Program|
|15270102||Liquid Serum Chemistry – Full Program|
|15290102||Neonatal Bilirubin – Full Program|
|15300102||On-Site Urine Toxicology Screening – Full Program|
|15310102||Oral Fluid Toxicology Screening – Full Program|
|15330102||Plasma Metanephrines – Full Program|
|15350102||PoCT Blood Gases – Full Program|
|15340102||PoCT Troponin and HCG – Full Program|
|15380102||Porphyrins – Faeces – Full Program|
|15390102||Porphyrins – Plasma – Full Program|
|15400102||Porphyrins – Urine – Full Program|
|15730102||Porphyrins – Urine Qual PBG only – Full Program|
|15370102||Porphyrins – Whole Blood – Full Program|
|15200102||Prostate Specific Antigen – Full Program|
|15430102||QAAMS ACR – Full Program|
|15440102||QAAMS HbA1c – Full Program|
|15210102||Red Cell Folate – Full Program|
|15480202||Roche Solutions Glucose Meters|
|15460102||Salivary Cortisol – Full Program|
|15470102||Serum Indices – Full Program|
|15510102||Special Drugs – Full Program|
|15490102||Special Lipids – Full Program|
|15520102||Sweat Testing – Full Program|
|15710102||Thiopurines – Full Program|
|15530102||Trace Elements – Blood – Full Program|
|15540102||Trace Elements – Serum – Full Program|
|15550102||Trace Elements – Urine – Full Program|
|15560102||Tumour Markers – Full Program|
|15570102||Urine Amylase – Full Program|
|15600102||Urine Pregnancy Testing – Full Program|
|15610102||Urine Toxicology – Full Program|
|15620102||Vitamin C – Full Program|
|15630102||Vitamins – Blood – Full Program|
|15640102||Vitamins – Serum – Full Program|
Recommended use: Quality Assurance/Proficiency Testing programs. Not to be used in the treatment and diagnosis of patients.
Chemical hazard: Not applicable
Environmental hazard: Not applicable
Health hazard: Exempt human specimens
No known test method can offer complete assurance that products derived from inactivated microorganisms and/or human sources will not transmit infection. All proficiency testing materials supplied by RCPAQAP must therefore be considered as a potential biohazard and should be handled appropriately and with care. The participant is responsible for the safe handling, storage and disposal of RCPAQAP proficiency testing materials in such a way that ensures that the proficiency testing materials will not cause any harm to any person.
The participant understands and acknowledges that, given the nature and characteristics of RCPAQAP proficiency testing materials;
- laboratory staff should be trained in the handling of infectious materials
- proficiency testing materials should be processed in a laboratory environment as identified by the relevant legislative requirements
- they are aware of all matters that concern the safe handling, storage and disposal of proficiency testing materials;
- they have the facilities and processes required for the safe handling, storage and disposal of proficiency testing materials;
- that they follow Standard Safety Precautions when handling potentially infectious materials.
- they utilise Personal Protective Equipment (PPE) as identified by the relevant legislative requirements for the routine handling of potentially infectious materials.
Composition and Information on Ingredients
Products contain the below components:
|Not Applicable||Human fluids and tissue||0–100%|
|Not Applicable||Aqueous solution of salts and gases||0–100%|
If accidental contact with material occurs laboratory staff should follow appropriate first aid procedures for exposure to an equivalent clinical specimen. Following exposure, medical advice should be sought. If accidental spillage occurs, follow routine procedures for clean-up of potentially biohazardous materials.
Not applicable, not flammable.
Accidental Release Measures
Personal protective equipment such as gloves, gown and protective eyewear should be used before cleaning any spills. Dispose any sharps in a safe disposal system. Clean the area with absorbent paper and clean excess with suitable disinfectant (such as bleach or 70% w/v alcohol).
Handling and Storage
On arrival, samples should be stored as per instructions on each sample kit. Samples have been shown to be stable when transported at ambient temperature.
Samples should be re-constituted or prepared according to Survey Instructions provided.
Exposure Controls and Personal Protection
Samples are only intended for processing in a clinical laboratory facility and should be handled in the same manner as routine patient samples using universal precautions and appropriate personal protective equipment. Biosafety Level 2 precautions at a minimum should be used.
Physical and Chemical Properties
Products may contain:
Whole blood: red and odourless, pH neutral
Blood spot: red and odourless, pH neutral
Serum/plasma: straw colour and odourless, pH neutral
Urine: straw colour and odourless, pH neutral
Lyophilised serum/urine: straw colour powder, pH neutral
CSF: clear to straw colour and odourless, pH neutral
Amniotic Fluid: clear to straw colour and odourless, pH neutral
Blood Gases only: Aqueous solution of salts and gases including sodium chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride, Lithium Lactate, Sodium Lactate, Sodium bicarbonate, Glucose, Urea and purified Bovine Albumin
Renal Calculus: Crystallised salts
Stability and Reactivity
This material is stable under normal temperatures and pressures, is non-corrosive, and polymerization will not occur.
Conditions to avoid: Avoid excess heat.
Tested and found non-reactive for the presence of hepatitis B surface antigen (HbsAg), human immunodeficiency virus antigen (HIV-1 Ag), antibody to hepatitis C virus (anti-HCV), and antibody to human immunodeficiency virus (anti-HIV-1/HIV-2).
Same bio-degradability as human blood, urine and other bodily fluids.
Dispose as clinical waste in suitably identified containers using a registered clinical waste disposal contractor (same as for patient samples).
Proper Shipping Name: Exempt Human Specimens
UN Number: Not Applicable
Hazard Class/Packing Group: Exempt Human Specimens
Labels Required: Exempt Human Specimens
IATA Packaging Requirements: Sample is not subject to the IATA Dangerous Goods Regulations as long as the specimen is transported in triple packaging that prevents leakage.
Reviewed annually as part of the RCPAQAP compliance with ISO/IEC 17043.
The information provided in this document is believed to be accurate and represents the best information currently available to us. The RCPAQAP make no warranty or merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability from its use. Users should make their own investigations to determine the suitability of the information for their particular purpose. In no event shall the RCPAQAP be liable for any claims, losses or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising from the use of this product or the information contained in the Material Safety Data Sheet.